These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6218280)

  • 1. Periodontal diseases and impaired neutrophil function.
    Van Dyke TE; Levine MJ; Al-Hashimi I; Genco RJ
    J Periodontal Res; 1982 Sep; 17(5):492-4. PubMed ID: 6218280
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotaxin receptors on human neutrophils: modulation of C5a and peptide receptor number.
    Nelson RD; Chenoweth DE; Solomkin JS; Solem LD
    Agents Actions Suppl; 1983; 12():274-89. PubMed ID: 6301231
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
    O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
    [No Abstract]   [Full Text] [Related]  

  • 4. 5,8,11,14-Eicosatetraynoic acid (ETYA) inhibits binding of N-formyl-methionyl-leucyl-phenylalanine (FLMP) to its receptor on human granulocytes. A note of caution.
    Atkinson JP; Simchowitz L; Mehta J; Stenson WF
    Immunopharmacology; 1982 Feb; 4(1):1-9. PubMed ID: 6277829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of vitamin K on human neutrophil function.
    Gallin JI; Seligmann BE; Cramer EB; Schiffmann E; Fletcher MP
    J Immunol; 1982 Mar; 128(3):1399-408. PubMed ID: 6276468
    [No Abstract]   [Full Text] [Related]  

  • 7. Two neutrophil populations in human blood with different chemotactic activities: separation and chemoattractant binding.
    Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):443-9. PubMed ID: 7085067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological changes in human polymorphonuclear leukocytes induced by C3a in the presence and absence of cytochalasin B.
    Showell HJ; Glovsky MM; Ward PA
    Int Arch Allergy Appl Immunol; 1982; 69(1):62-7. PubMed ID: 6980842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.
    Clark RA; Szot S
    J Immunol; 1982 Apr; 128(4):1507-13. PubMed ID: 6278020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ; Leid RW
    Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation products and monocyte migratory function in trauma.
    Antrum RM; Solomkin JS
    Curr Surg; 1985; 42(4):301-3. PubMed ID: 3875452
    [No Abstract]   [Full Text] [Related]  

  • 13. Extra- and intracellular Ca2+ requirements for lysosomal enzyme secretion in human neutrophils.
    Shaw JO; Brodersen I; Lyons RM
    Agents Actions; 1982 Jul; 12(3):328-32. PubMed ID: 6814207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of culturing on the human lymphocyte locomotion response to casein, C5a, and fMet-Leu-Phe.
    El-Naggar A; Van Epps DE; Williams RC
    Cell Immunol; 1981 May; 60(1):43-9. PubMed ID: 7237565
    [No Abstract]   [Full Text] [Related]  

  • 15. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic factor-induced membrane potential changes in rabbit neutrophils monitored by the fluorescent dye 3,3'-dipropylthiadicarbocyanine iodide.
    Tatham PE; Delves PJ; Shen L; Roitt IM
    Biochim Biophys Acta; 1980 Nov; 602(2):285-98. PubMed ID: 7426651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte chemoattractant receptors.
    Pike MC; Snyderman R
    Methods Enzymol; 1988; 162():236-45. PubMed ID: 3226308
    [No Abstract]   [Full Text] [Related]  

  • 18. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the inflammatory response by the neutrophil myeloperoxidase system.
    Clark RA
    Adv Exp Med Biol; 1982; 141():207-16. PubMed ID: 6283824
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of hexose transport in human polymorphonuclear leukocytes.
    McCall CE; Bass DA; Thomas M; O'Flaherty JT; DeChatelet LR
    Adv Exp Med Biol; 1982; 141():539-47. PubMed ID: 6807068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.